Summary.-The combination of a single dose of razoxane (ICRF 159) with a single dose of electron radiation has been studied with the murine sarcoma S180. A drug dose of 30 mg/kg combined with radiation produced a greater tumour response than either agent alone, but it was not possible to establish whether the effect was more than additive.
THE COMBINATION of the drug, razoxane (ICRF 159 (±) 1,2-di(3,5-dioxopiperazin-1-yl propane) and irradiation has been uised in several recent clinical studies (e.g. Ryall et al., 1979; Spittle et al., 1979) . The first report of an effect of the drug in a murine system was by Hellmann & Murkin (1974) using Sarcoma 180 and a fractionated radiation/drug regime. Razoxane alone was reported to have a "normalizing" effect on the vasculature of experimental tumours with poorly developed blood vessels (Salsbury et al., 1974) . The suggestion was made by Hellmann and Murkin that their observations could have been brought about by the effect of razoxane on the developing tumour neovasculature, indirectly sensitizing the hypoxic cells in the tumour.
However, preliminary studies by Barker Grimshaw (unpublished) indicated that some additional tumour response was manifest when razoxane was administered as a single dose 1 h before a single dose of X-rays (i.e. before any gross structural alteration in the tumour neovasculature could have occurred).
An alternative mechanism by which razoxane could be affecting radiation response would be by altering the tissue 02 concentration. Miko & Chance (1974) reported that razoxane inhibited endogenous respiration of Ehrlich Lettre cells in vitro. Such inhibition, if occurring in vivo, would allow 02 to diffuse to a greater distance from blood capillaries and hence oxygenate previously hypoxic (but possibly clonogenic) tumour cells. Some evidence for increased tumour 02 concentration following razoxane treatment came from the work of Norpoth et al. (1974) and unpublished work of the present authors. However, in both cases the tumour used had been given repeated doses of razoxane.
The work presented here set out concurrently to investigate the effect on a mouse sarcoma of a single razoxane treatment combined with a single dose of ionizing radiation; the effect of different doses of razoxane on tumour and normal-tissue 02 concentration; and the effect of razoxane on tumour-cell respiration.
MATERIALS AND METHODS
The murine sarcoma 180 (S180) w%Nas used in these experiments. For tumour-response studies, 1-month-old, male, Schneider mice were inoculated s.c. in the flank with 107 S180 cells in 0-1 cm3 sterile mash. Ten days after implantation, mice the tumours of which had reached a volume of -0 5 cm3 were randomized into groups of 10 and given the various treatments.
The drug razoxane was made up as a fine suspension in carboxymethyl cellulose (CMC) as described by Hellmann & Murkin (1974) . Drug concentrations were adjusted so that mice received i.p. injections of 0-2-0-3 cm3 according to their body weight. Control animals received i.p. injections of the appropriate volume of CMC.
For irradiation or measurements of tissue 02 concentration, animals were anaesthetized with Avertin (tribromoethanol (Winthrop), 250 mg/kg) which rendered the mice comatose for 30 min.
Tumour response.-Tumour response to the various treatments was assessed by measuring tumour volumes thrice weekly starting on the treatment day (Day 10 after implantation). Three perpendicular measurements of tumour diameter were taken using Vernier calipers, and the product, the '"relative tumour volume" for each treatment group was plotted against time from the start of treatment, to produce a tumour growrth curve, after first relating the mean group tumour size to the mean size on the first day of treatment. On Day 28 the mean tumour volume of untreated animals was Hellmann and Murkin (1974) . Three doses of razoxane were used in the present experiments: 6-25, 15 and 30 mg/kg. The pretreated mice were anaesthetized with Avertin just before irradiation and placed singly on a Perspex platform which could be mounted vertically behind a collimator in the electron beam. The radiation field was defined by an Al-Pb collimator with suitable hole to include the tumour. Ionization chambers were used to monitor the incident electron beam, and calibrations carried out so that the beam could be switched off automatically when the required dose had been delivered to the tumours. Lithium fluoride powder in sachets was used to confirm the doses. Groups of mice were given 1-5, 3 or 6 Gy of 15-4MeV electrons from a linear accelerator at a dose rate of 11 Gy/s. Although the total time the mice spent in the irradiation room was only about 2 min, they were gassed with warmed air (28°C, flowr rate 6 1/min, ambient temperature 24°C) to ensure that their tissues remained normally oxygenated and to maintain body temperature. Oxygen cathode measurenien,ts.-The construction and use of the electrodes and the measuring apparatus have been described elsewhere (Davies & Hall. 1973; Shew ell & Davies, 1977; Roberts et al. (1975) .
Electrodes were calibrated at the start of every experiment in air-saturated physiological saline at 37°C. Solutions containing razoxane at concentrations up to the equivalent of 1000 mg/kg in animals had no effect on the electrodes.
Mice were treated w%iith razoxane or CMC, 1 h before tissue 02 measurements. Four doses of razoxane were used: 15, 30, 100 and 500 mg/kg. Fifty min later 2 mice were anaesthetized with Avertin, 1 CMC-treated and 1 razoxane-treated. The fur over the tumours was gently trimmed. The mice Mere then positioned supine on a Perspex platform and restrained with adhesive tape.
Two electrodes were placed into each tumour and one electrode placed s.c., a 25-gauge needle being used to facilitate skin penetration. A reference electrode was positioned in the rectum.
The platform was then placed in a polythene bag with an air or 02 inlet at one end, the other end remaining open. A lamp was positioned above the mice to maintain body temperature. Electrode readings were taken every minute until a steady state was reached (5-10 min). 100% 02 at atmospheric pressure was then passed through the bag at 41/min, again until steady state was attained. After each experiment, the depth of penetration of each electrode was recorded and the mice killed.
Cell respiration .-Schneider mice bearing the S180 tumour in the ascitic form were killed 7 days after i.p. tumour transplantation, and the ascites fluid added to ice-cold E4 medium (Eagle's medium, Dulbecco's modification, made up by the Central Service Division of the ICRF). The cell suspension was centrifuged at 800 rev/min for 10 min, and any contaminating erythrocytes removed by the hypertonic lysis method (Chance & Hess, 1959) . Cells w%Nere resuspended in E4 Thus stocks of cells which had been treated with the drug at 37°C for 1 h remained exposed to the drug during storage on ice before the respiration studies.
Oxygen consumption was measured with a Clark-type electrode calibrated with 3 cm3 air-saturated physiological saline at 37°C. About 107 S180 cells in 3 cm3 E4 were added to the reaction vessel, and after 5min equilibration the fall in current with time was recorded. Usually 107 cells used up all the available 02 in about 10 min.
RESULTS
Tumour response to treatment with razoxane, electron radiation or both
The data for the tumour response of groups of 10 mice treated in various ways are shown in Fig. 1 
Cell respiration
The effect of 1 h incubation with razoxane (0, 10, 100, or 1000 ,ug/cm3) on the 02 consumption of S180 cells is shown in the Table. It is apparent that razoxane for 1 h at 37TC does not significantly influence 02 consumption. Indeed, when the experiments were repeated with razoxane included in the medium of the stock cell suspension kept on ice, there was again no detectable difference between oxygen consumption for control and treated cells. (Denekamp & Harris, 1975) . However, this problem can be solved by measuring the area under the tumour growth curve between the time limits of treatment day and final measurement day (see Methods). This method was therefore the one of choice and results were expressed using the T/C ratio. The combination of 30 mg/kg razoxane and radiation produced a greater relative tumour response than for either agent alone. It was not possible to establish whether the effect was only additive with the data available but neither 6-25 mg/kg nor 15 mg/kg razoxane in combination with radiation produced an effect greater than with only one agent.
The direct measurements of tumour 02 for air-breathing animals were no different from measurements commonly found in experimental tumours. The results for animals treated with drug doses within the range used in the radiation studies were not different from control values. At the higher drug dose, 100 mg/kg, there is a deviation from the control value, but this is not apparent at the highest clrug dose used, 500 mg/kg. Oxygen-breathing animals, given no razoxane, had a raised 02 concentration, and this was also found in animals treated with the lowest and highest razoxane doses (15 and 500 mg/kg). However, doses of 30 and 100 mg/kg apparently reduiced the relative increase in tumour 02 concentration when breathing 02 rather than air. This is the; reverse of what would be expected if increased tumour 02 concentration were to explain the radiation result. This unexpected dose-effect relationship may be due to the absorption characteristics of razoxane. Problems with the absorption of orally administered razoxane have been noted (Creaven et al., 1974 Kruuv et al. (1967) .
In conclusion, our tumour-response data support the view of others (Taylor & Bleehen, 1977 ) that razoxane-induced changes in the developing neovasculature are not a necessary requirement for producing increased radiation effects.
The direct 02 cathode measurements suggest that razoxane does not affect tumour 02 concentration over the range of drug doses used in the radiation studies. Variations seen at higher drug doses may be due to the absorption characteristics of the drug. In vitro studies of tumour-cell respiration revealed no change in 02 consumption, even at the highest drug dose.
There is no need, therefore, for changes in tumour 02, from whatever cause, to explain the increased radiation response seen with S180, and the particular treatment schedule used above. A range of tumour types and schedules needs to be investigated before this possible mode of action can be eliminated.
The varied biological properties of razoxane have elicited many suggestions as to its mode of enhancing the radiation response. Razoxane may well enhance radiation via a number of different mechanisms and the contribution of any one of these to the final result may differ according to the tumour and treatment schedule used. This may well be why the combination of razoxane with radiation has produced conflicting results; e.g. Peters, 1976; Sheldon & Hill, 1977; Bakowski et al., 1978; Bates, 1978; Hellmann et al., 1978; Ryall et al., 1979. 
